These isoforms retain different features of TP53, suggesting that abnormal expression of the p53 isoforms may contribute to the loss of p53 tumor-suppressor activity in BrCa, indicating that several alternatively spliced genes could be involved in the same cell proliferation/survival pathways contributing to cell fate in different directions [105]. The gene discussed is TP53; the disease is neoplasm.